PositoAI/ JP/ Solasia Pharma K.K.

Solasia Pharma K.K.

Tokyo: 4597 · Healthcare

Positivity Index

#9,076 / 10,750

Global

#3,514 / 3,683

Japan

Positivity Score

17,809

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: not checked yet

Solasia Pharma K.K. — Overview & Financial Snapshot

Solasia Pharma K.K. (Tokyo: 4597) is a Healthcare company, ranked #9,076 of 10,750 companies globally and #3,514 of 3,683 in Japan on PositoAI, with a Positivity Score of 17,809. Its market capitalisation is ₹462.75 Cr (¥7.64B), P/E ratio is -8.5 and P/B ratio is 5.26. Red flags (PosiRed) are not checked yet for companies in this market.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#3 Wel-Dish.Incorporated 27,767 #19 Kohjin Bio Co., Ltd. 25,943 #40 MTI Ltd. 25,486 #49 GIMIC Co., Ltd. 25,357 #59 PhoenixBio Co., Ltd. 25,246

— Nothing to show —

OpenAI is reading recent news...

Solasia Pharma K.K. develops, markets, imports, and exports pharmaceutical products and medical devices in Japan, China, South Korea, and internationally. The company offers Episil (SP-03), an oral liquid for oral mucositis/stomatitis; DARVIAS (SP-02), an antineoplastic agent injection for relapsed or refractory peripheral T-cell lymphoma; and Sancuso (SP-01) for chemotherapy-induced nausea and vomiting. It also develops SP-04, which is in a preclinical trial for chemotherapy-induced peripheral neuropathy; and SP-05, which is in a preclinical trial for colorectal cancer. The company was formerly known as JapanBridge, Inc. and changed its name to Solasia Pharma K.K. in September 2008. Solasia Pharma K.K. was founded in 2006 and is headquartered in Minato, Japan.

P/B Ratio 5.26

P/E Ratio -8.5

D/E Ratio 0.05

ROE -65.98%

Owes vs Owns ? 0.23× Low ¥0.23 owed for every ¥1 it owns · balance sheet Jun 2026

Dividend Yield 0.00%

Trailing EPS ₹-1.99¥-3.29

Forward EPS ₹-1.27¥-2.10

Beta 1.18

Market Cap ₹462.75 Cr¥7.64B

What these numbers mean →

What does Solasia Pharma K.K. do?

What is Solasia Pharma K.K.'s P/E and P/B ratio?

Solasia Pharma K.K. has a P/E ratio of -8.5 and a P/B ratio of 5.26.

What is Solasia Pharma K.K.'s debt-to-equity ratio?

Solasia Pharma K.K. has a debt-to-equity ratio of 0.05.

How much does Solasia Pharma K.K. owe compared with what it owns?

Solasia Pharma K.K. owes ¥0.23 for every ¥1 it owns (balance sheet Jun 2026), which is low.

What is Solasia Pharma K.K.'s Positivity rank?

Solasia Pharma K.K. is ranked #9,076 of 10,750 companies globally and #3,514 of 3,683 in Japan on PositoAI, with a Positivity Score of 17,809.

Does Solasia Pharma K.K. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Red flags (PosiRed) are not checked yet for companies in this market on PositoAI, so no result is shown for Solasia Pharma K.K..

Where can I read the latest news about Solasia Pharma K.K.?

Recent headlines about Solasia Pharma K.K. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Solasia Pharma K.K. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Solasia Pharma K.K.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.